The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravenous Antibodies Market Research Report 2024
Synopsis
The global Intravenous Antibodies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Intravenous Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intravenous Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intravenous Antibodies include Baxter International, CSL Limited, Biotest AG, OMRIX Biopharmaceuticals, Octapharma AG, Grifols, S.A, Guizhou Taibang Biological Products, Shanghai RAAS Blood Products and Hualan Biological Engineering, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intravenous Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Antibodies.
Report Scope
The Intravenous Antibodies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter International
CSL Limited
Biotest AG
OMRIX Biopharmaceuticals
Octapharma AG
Grifols, S.A
Guizhou Taibang Biological Products
Shanghai RAAS Blood Products
Hualan Biological Engineering
Kedrion S.p.A.
Beijing Tiantan Biological Products
China Biologic Products
Segment by Type
IgG
IgA
IgM
IgE
IgD
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Intravenous Antibodies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Intravenous Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intravenous Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intravenous Antibodies include Baxter International, CSL Limited, Biotest AG, OMRIX Biopharmaceuticals, Octapharma AG, Grifols, S.A, Guizhou Taibang Biological Products, Shanghai RAAS Blood Products and Hualan Biological Engineering, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intravenous Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Antibodies.
Report Scope
The Intravenous Antibodies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter International
CSL Limited
Biotest AG
OMRIX Biopharmaceuticals
Octapharma AG
Grifols, S.A
Guizhou Taibang Biological Products
Shanghai RAAS Blood Products
Hualan Biological Engineering
Kedrion S.p.A.
Beijing Tiantan Biological Products
China Biologic Products
Segment by Type
IgG
IgA
IgM
IgE
IgD
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intravenous Antibodies Market Overview
1.1 Product Overview and Scope of Intravenous Antibodies
1.2 Intravenous Antibodies Segment by Type
1.2.1 Global Intravenous Antibodies Market Value Comparison by Type (2024-2030)
1.2.2 IgG
1.2.3 IgA
1.2.4 IgM
1.2.5 IgE
1.2.6 IgD
1.3 Intravenous Antibodies Segment by Application
1.3.1 Global Intravenous Antibodies Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Intravenous Antibodies Market Size Estimates and Forecasts
1.4.1 Global Intravenous Antibodies Revenue 2019-2030
1.4.2 Global Intravenous Antibodies Sales 2019-2030
1.4.3 Global Intravenous Antibodies Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravenous Antibodies Market Competition by Manufacturers
2.1 Global Intravenous Antibodies Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravenous Antibodies Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravenous Antibodies Average Price by Manufacturers (2019-2024)
2.4 Global Intravenous Antibodies Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Antibodies, Product Type & Application
2.7 Intravenous Antibodies Market Competitive Situation and Trends
2.7.1 Intravenous Antibodies Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Antibodies Players Market Share by Revenue
2.7.3 Global Intravenous Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Antibodies Retrospective Market Scenario by Region
3.1 Global Intravenous Antibodies Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravenous Antibodies Global Intravenous Antibodies Sales by Region: 2019-2030
3.2.1 Global Intravenous Antibodies Sales by Region: 2019-2024
3.2.2 Global Intravenous Antibodies Sales by Region: 2025-2030
3.3 Global Intravenous Antibodies Global Intravenous Antibodies Revenue by Region: 2019-2030
3.3.1 Global Intravenous Antibodies Revenue by Region: 2019-2024
3.3.2 Global Intravenous Antibodies Revenue by Region: 2025-2030
3.4 North America Intravenous Antibodies Market Facts & Figures by Country
3.4.1 North America Intravenous Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravenous Antibodies Sales by Country (2019-2030)
3.4.3 North America Intravenous Antibodies Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous Antibodies Market Facts & Figures by Country
3.5.1 Europe Intravenous Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravenous Antibodies Sales by Country (2019-2030)
3.5.3 Europe Intravenous Antibodies Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Antibodies Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravenous Antibodies Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravenous Antibodies Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Antibodies Market Facts & Figures by Country
3.7.1 Latin America Intravenous Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravenous Antibodies Sales by Country (2019-2030)
3.7.3 Latin America Intravenous Antibodies Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravenous Antibodies Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravenous Antibodies Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Antibodies Sales by Type (2019-2030)
4.1.1 Global Intravenous Antibodies Sales by Type (2019-2024)
4.1.2 Global Intravenous Antibodies Sales by Type (2025-2030)
4.1.3 Global Intravenous Antibodies Sales Market Share by Type (2019-2030)
4.2 Global Intravenous Antibodies Revenue by Type (2019-2030)
4.2.1 Global Intravenous Antibodies Revenue by Type (2019-2024)
4.2.2 Global Intravenous Antibodies Revenue by Type (2025-2030)
4.2.3 Global Intravenous Antibodies Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous Antibodies Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intravenous Antibodies Sales by Application (2019-2030)
5.1.1 Global Intravenous Antibodies Sales by Application (2019-2024)
5.1.2 Global Intravenous Antibodies Sales by Application (2025-2030)
5.1.3 Global Intravenous Antibodies Sales Market Share by Application (2019-2030)
5.2 Global Intravenous Antibodies Revenue by Application (2019-2030)
5.2.1 Global Intravenous Antibodies Revenue by Application (2019-2024)
5.2.2 Global Intravenous Antibodies Revenue by Application (2025-2030)
5.2.3 Global Intravenous Antibodies Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous Antibodies Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter International
6.1.1 Baxter International Corporation Information
6.1.2 Baxter International Description and Business Overview
6.1.3 Baxter International Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter International Intravenous Antibodies Product Portfolio
6.1.5 Baxter International Recent Developments/Updates
6.2 CSL Limited
6.2.1 CSL Limited Corporation Information
6.2.2 CSL Limited Description and Business Overview
6.2.3 CSL Limited Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Limited Intravenous Antibodies Product Portfolio
6.2.5 CSL Limited Recent Developments/Updates
6.3 Biotest AG
6.3.1 Biotest AG Corporation Information
6.3.2 Biotest AG Description and Business Overview
6.3.3 Biotest AG Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biotest AG Intravenous Antibodies Product Portfolio
6.3.5 Biotest AG Recent Developments/Updates
6.4 OMRIX Biopharmaceuticals
6.4.1 OMRIX Biopharmaceuticals Corporation Information
6.4.2 OMRIX Biopharmaceuticals Description and Business Overview
6.4.3 OMRIX Biopharmaceuticals Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 OMRIX Biopharmaceuticals Intravenous Antibodies Product Portfolio
6.4.5 OMRIX Biopharmaceuticals Recent Developments/Updates
6.5 Octapharma AG
6.5.1 Octapharma AG Corporation Information
6.5.2 Octapharma AG Description and Business Overview
6.5.3 Octapharma AG Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Octapharma AG Intravenous Antibodies Product Portfolio
6.5.5 Octapharma AG Recent Developments/Updates
6.6 Grifols, S.A
6.6.1 Grifols, S.A Corporation Information
6.6.2 Grifols, S.A Description and Business Overview
6.6.3 Grifols, S.A Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Grifols, S.A Intravenous Antibodies Product Portfolio
6.6.5 Grifols, S.A Recent Developments/Updates
6.7 Guizhou Taibang Biological Products
6.6.1 Guizhou Taibang Biological Products Corporation Information
6.6.2 Guizhou Taibang Biological Products Description and Business Overview
6.6.3 Guizhou Taibang Biological Products Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guizhou Taibang Biological Products Intravenous Antibodies Product Portfolio
6.7.5 Guizhou Taibang Biological Products Recent Developments/Updates
6.8 Shanghai RAAS Blood Products
6.8.1 Shanghai RAAS Blood Products Corporation Information
6.8.2 Shanghai RAAS Blood Products Description and Business Overview
6.8.3 Shanghai RAAS Blood Products Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shanghai RAAS Blood Products Intravenous Antibodies Product Portfolio
6.8.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.9 Hualan Biological Engineering
6.9.1 Hualan Biological Engineering Corporation Information
6.9.2 Hualan Biological Engineering Description and Business Overview
6.9.3 Hualan Biological Engineering Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hualan Biological Engineering Intravenous Antibodies Product Portfolio
6.9.5 Hualan Biological Engineering Recent Developments/Updates
6.10 Kedrion S.p.A.
6.10.1 Kedrion S.p.A. Corporation Information
6.10.2 Kedrion S.p.A. Description and Business Overview
6.10.3 Kedrion S.p.A. Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Kedrion S.p.A. Intravenous Antibodies Product Portfolio
6.10.5 Kedrion S.p.A. Recent Developments/Updates
6.11 Beijing Tiantan Biological Products
6.11.1 Beijing Tiantan Biological Products Corporation Information
6.11.2 Beijing Tiantan Biological Products Intravenous Antibodies Description and Business Overview
6.11.3 Beijing Tiantan Biological Products Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Beijing Tiantan Biological Products Intravenous Antibodies Product Portfolio
6.11.5 Beijing Tiantan Biological Products Recent Developments/Updates
6.12 China Biologic Products
6.12.1 China Biologic Products Corporation Information
6.12.2 China Biologic Products Intravenous Antibodies Description and Business Overview
6.12.3 China Biologic Products Intravenous Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.12.4 China Biologic Products Intravenous Antibodies Product Portfolio
6.12.5 China Biologic Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Antibodies Industry Chain Analysis
7.2 Intravenous Antibodies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Antibodies Production Mode & Process
7.4 Intravenous Antibodies Sales and Marketing
7.4.1 Intravenous Antibodies Sales Channels
7.4.2 Intravenous Antibodies Distributors
7.5 Intravenous Antibodies Customers
8 Intravenous Antibodies Market Dynamics
8.1 Intravenous Antibodies Industry Trends
8.2 Intravenous Antibodies Market Drivers
8.3 Intravenous Antibodies Market Challenges
8.4 Intravenous Antibodies Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Intravenous Antibodies Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Intravenous Antibodies Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Intravenous Antibodies Market Competitive Situation by Manufacturers in 2023
Table 4. Global Intravenous Antibodies Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Intravenous Antibodies Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Intravenous Antibodies Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Intravenous Antibodies Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Intravenous Antibodies Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Intravenous Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Intravenous Antibodies, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intravenous Antibodies, Product Type & Application
Table 12. Global Key Manufacturers of Intravenous Antibodies, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravenous Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Antibodies as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravenous Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Intravenous Antibodies Sales by Region (2019-2024) & (K Units)
Table 18. Global Intravenous Antibodies Sales Market Share by Region (2019-2024)
Table 19. Global Intravenous Antibodies Sales by Region (2025-2030) & (K Units)
Table 20. Global Intravenous Antibodies Sales Market Share by Region (2025-2030)
Table 21. Global Intravenous Antibodies Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Intravenous Antibodies Revenue Market Share by Region (2019-2024)
Table 23. Global Intravenous Antibodies Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Intravenous Antibodies Revenue Market Share by Region (2025-2030)
Table 25. North America Intravenous Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Intravenous Antibodies Sales by Country (2019-2024) & (K Units)
Table 27. North America Intravenous Antibodies Sales by Country (2025-2030) & (K Units)
Table 28. North America Intravenous Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Intravenous Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Intravenous Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Intravenous Antibodies Sales by Country (2019-2024) & (K Units)
Table 32. Europe Intravenous Antibodies Sales by Country (2025-2030) & (K Units)
Table 33. Europe Intravenous Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Intravenous Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Intravenous Antibodies Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Intravenous Antibodies Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Intravenous Antibodies Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Intravenous Antibodies Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Intravenous Antibodies Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Intravenous Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Intravenous Antibodies Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Intravenous Antibodies Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Intravenous Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Intravenous Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Intravenous Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Intravenous Antibodies Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Intravenous Antibodies Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Intravenous Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Intravenous Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Intravenous Antibodies Sales (K Units) by Type (2019-2024)
Table 51. Global Intravenous Antibodies Sales (K Units) by Type (2025-2030)
Table 52. Global Intravenous Antibodies Sales Market Share by Type (2019-2024)
Table 53. Global Intravenous Antibodies Sales Market Share by Type (2025-2030)
Table 54. Global Intravenous Antibodies Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Intravenous Antibodies Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Intravenous Antibodies Revenue Market Share by Type (2019-2024)
Table 57. Global Intravenous Antibodies Revenue Market Share by Type (2025-2030)
Table 58. Global Intravenous Antibodies Price (US$/Unit) by Type (2019-2024)
Table 59. Global Intravenous Antibodies Price (US$/Unit) by Type (2025-2030)
Table 60. Global Intravenous Antibodies Sales (K Units) by Application (2019-2024)
Table 61. Global Intravenous Antibodies Sales (K Units) by Application (2025-2030)
Table 62. Global Intravenous Antibodies Sales Market Share by Application (2019-2024)
Table 63. Global Intravenous Antibodies Sales Market Share by Application (2025-2030)
Table 64. Global Intravenous Antibodies Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Intravenous Antibodies Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Intravenous Antibodies Revenue Market Share by Application (2019-2024)
Table 67. Global Intravenous Antibodies Revenue Market Share by Application (2025-2030)
Table 68. Global Intravenous Antibodies Price (US$/Unit) by Application (2019-2024)
Table 69. Global Intravenous Antibodies Price (US$/Unit) by Application (2025-2030)
Table 70. Baxter International Corporation Information
Table 71. Baxter International Description and Business Overview
Table 72. Baxter International Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Baxter International Intravenous Antibodies Product
Table 74. Baxter International Recent Developments/Updates
Table 75. CSL Limited Corporation Information
Table 76. CSL Limited Description and Business Overview
Table 77. CSL Limited Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. CSL Limited Intravenous Antibodies Product
Table 79. CSL Limited Recent Developments/Updates
Table 80. Biotest AG Corporation Information
Table 81. Biotest AG Description and Business Overview
Table 82. Biotest AG Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Biotest AG Intravenous Antibodies Product
Table 84. Biotest AG Recent Developments/Updates
Table 85. OMRIX Biopharmaceuticals Corporation Information
Table 86. OMRIX Biopharmaceuticals Description and Business Overview
Table 87. OMRIX Biopharmaceuticals Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. OMRIX Biopharmaceuticals Intravenous Antibodies Product
Table 89. OMRIX Biopharmaceuticals Recent Developments/Updates
Table 90. Octapharma AG Corporation Information
Table 91. Octapharma AG Description and Business Overview
Table 92. Octapharma AG Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Octapharma AG Intravenous Antibodies Product
Table 94. Octapharma AG Recent Developments/Updates
Table 95. Grifols, S.A Corporation Information
Table 96. Grifols, S.A Description and Business Overview
Table 97. Grifols, S.A Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Grifols, S.A Intravenous Antibodies Product
Table 99. Grifols, S.A Recent Developments/Updates
Table 100. Guizhou Taibang Biological Products Corporation Information
Table 101. Guizhou Taibang Biological Products Description and Business Overview
Table 102. Guizhou Taibang Biological Products Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Guizhou Taibang Biological Products Intravenous Antibodies Product
Table 104. Guizhou Taibang Biological Products Recent Developments/Updates
Table 105. Shanghai RAAS Blood Products Corporation Information
Table 106. Shanghai RAAS Blood Products Description and Business Overview
Table 107. Shanghai RAAS Blood Products Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Shanghai RAAS Blood Products Intravenous Antibodies Product
Table 109. Shanghai RAAS Blood Products Recent Developments/Updates
Table 110. Hualan Biological Engineering Corporation Information
Table 111. Hualan Biological Engineering Description and Business Overview
Table 112. Hualan Biological Engineering Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Hualan Biological Engineering Intravenous Antibodies Product
Table 114. Hualan Biological Engineering Recent Developments/Updates
Table 115. Kedrion S.p.A. Corporation Information
Table 116. Kedrion S.p.A. Description and Business Overview
Table 117. Kedrion S.p.A. Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Kedrion S.p.A. Intravenous Antibodies Product
Table 119. Kedrion S.p.A. Recent Developments/Updates
Table 120. Beijing Tiantan Biological Products Corporation Information
Table 121. Beijing Tiantan Biological Products Description and Business Overview
Table 122. Beijing Tiantan Biological Products Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Beijing Tiantan Biological Products Intravenous Antibodies Product
Table 124. Beijing Tiantan Biological Products Recent Developments/Updates
Table 125. China Biologic Products Corporation Information
Table 126. China Biologic Products Description and Business Overview
Table 127. China Biologic Products Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. China Biologic Products Intravenous Antibodies Product
Table 129. China Biologic Products Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Intravenous Antibodies Distributors List
Table 133. Intravenous Antibodies Customers List
Table 134. Intravenous Antibodies Market Trends
Table 135. Intravenous Antibodies Market Drivers
Table 136. Intravenous Antibodies Market Challenges
Table 137. Intravenous Antibodies Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intravenous Antibodies
Figure 2. Global Intravenous Antibodies Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Intravenous Antibodies Market Share by Type in 2023 & 2030
Figure 4. IgG Product Picture
Figure 5. IgA Product Picture
Figure 6. IgM Product Picture
Figure 7. IgE Product Picture
Figure 8. IgD Product Picture
Figure 9. Global Intravenous Antibodies Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Intravenous Antibodies Market Share by Application in 2023 & 2030
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Others
Figure 14. Global Intravenous Antibodies Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Intravenous Antibodies Market Size (2019-2030) & (US$ Million)
Figure 16. Global Intravenous Antibodies Sales (2019-2030) & (K Units)
Figure 17. Global Intravenous Antibodies Average Price (US$/Unit) & (2019-2030)
Figure 18. Intravenous Antibodies Report Years Considered
Figure 19. Intravenous Antibodies Sales Share by Manufacturers in 2023
Figure 20. Global Intravenous Antibodies Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Intravenous Antibodies Players: Market Share by Revenue in 2023
Figure 22. Intravenous Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Intravenous Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Intravenous Antibodies Sales Market Share by Country (2019-2030)
Figure 25. North America Intravenous Antibodies Revenue Market Share by Country (2019-2030)
Figure 26. United States Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Intravenous Antibodies Sales Market Share by Country (2019-2030)
Figure 29. Europe Intravenous Antibodies Revenue Market Share by Country (2019-2030)
Figure 30. Germany Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Intravenous Antibodies Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Intravenous Antibodies Revenue Market Share by Region (2019-2030)
Figure 37. China Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Intravenous Antibodies Sales Market Share by Country (2019-2030)
Figure 47. Latin America Intravenous Antibodies Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Intravenous Antibodies Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Intravenous Antibodies Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Intravenous Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Intravenous Antibodies by Type (2019-2030)
Figure 57. Global Revenue Market Share of Intravenous Antibodies by Type (2019-2030)
Figure 58. Global Intravenous Antibodies Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Intravenous Antibodies by Application (2019-2030)
Figure 60. Global Revenue Market Share of Intravenous Antibodies by Application (2019-2030)
Figure 61. Global Intravenous Antibodies Price (US$/Unit) by Application (2019-2030)
Figure 62. Intravenous Antibodies Value Chain
Figure 63. Intravenous Antibodies Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
